Opinion|Videos|June 21, 2024

Atopic Dermatitis: Topical Therapies and Unmet Needs in the Treatment Landscape

Key opinion leaders provide a concise overview of the atopic dermatitis (AD) treatment landscape, focusing on the role of topical therapy, and highlight the current unmet needs in AD management.

  1. Provide a brief overview of the treatment landscape, and where topical therapies and systemic therapies fit into this landscape. What are the current unmet needs from your perspective?
  2. Please incorporate a discussion of the following topical therapies:
  3. Corticosteroids
  4. Crisaborole – AD-301/AD-302, CrisADe CARE 1 
  5. Ruxolitinib – TRuE-AD1/TRuE-AD2 – original publication, long-term follow up

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo